Paris, France

Stéphane Emiliani

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2010-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Stéphane Emiliani: Innovator in HIV Research

Introduction

Stéphane Emiliani is a notable inventor based in Paris, France. He has made significant contributions to the field of HIV research, particularly through his innovative patents. With a total of 2 patents, Emiliani's work focuses on understanding and modulating protein-protein interactions involved in AIDS.

Latest Patents

Emiliani's latest patents include groundbreaking research on human immunodeficiency virus integrase and its interactions with various proteins. One of his patents addresses the protein-protein interactions involved in AIDS, specifically relating to complexes of polypeptides or polynucleotides encoding these polypeptides. This invention also includes methods for screening drugs that can modulate these interactions, along with pharmaceutical compositions designed for the same purpose. Another patent similarly explores the interactions between human immunodeficiency virus integrase and the LEDGF p75 isoform, further contributing to the understanding of AIDS-related protein interactions.

Career Highlights

Throughout his career, Stéphane Emiliani has worked with several prominent companies, including Cellvir and Laboratoire Biodim. His research has been pivotal in advancing the scientific community's understanding of HIV and its mechanisms. Emiliani's innovative approach has positioned him as a key figure in the field of virology.

Collaborations

Emiliani has collaborated with notable colleagues such as Pierre Legrain and Jean-Christophe Rain. These partnerships have enhanced his research efforts and contributed to the development of his patents.

Conclusion

Stéphane Emiliani's contributions to HIV research through his patents highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in understanding and treating AIDS.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…